Posted 4/5/2024, 2:10:03 PM
Varda Space Raises $90M After First Orbit Mission to Reformulate HIV Drug
- Varda Space Industries raised $90M in Series B funding after success of first orbital pharmaceutical manufacturing mission
- Mission returned after 10 months with experiment to reformulate HIV drug ritonavir
- Varda developing new hyper-gravity crystallization methods as screening before microgravity experiments
- Aims to increase launch cadence before focusing on reusability, targeting $2.5M per mission by 2027
- Has contracts with public biotech companies; next mission launches later this year
